000			02029nam a22002417a 4500
999			_c65596 _d65596
008			200610b2018 ||||| |||| 00| 0 eng d
020			_a9783319724157
082			_a615.7045 PAI-M
100			_aPai, Manjunath P
245			_aDrug interactions in infectious diseases : _bantimicrobial drug / _cManjunath P. Pai...[et.al.,]
250			_a4th ed.,
260			_aIndia _bHuman Press _c2018
300			_a565 p.
365			_aEU _b169.99.
500			_aThe 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”. This volume, “Antimicrobial Drug Interactions,” delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners.
650			_aCommunicable diseases
650			_aDrug interactions
650			_aAnti-infective agents
650			_aMedicine
650			_aPharmaceutical technology
650			_aPharmacy
650			_aAnti-infective agents--Side effects